Correlation Between Dermata Therapeutics and Brainstorm Cell
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Brainstorm Cell.
Diversification Opportunities for Dermata Therapeutics and Brainstorm Cell
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dermata and Brainstorm is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Brainstorm Cell go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Brainstorm Cell
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.51 times more return on investment than Brainstorm Cell. However, Dermata Therapeutics is 1.51 times more volatile than Brainstorm Cell Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Brainstorm Cell Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 123.00 in Dermata Therapeutics on December 2, 2024 and sell it today you would lose (9.00) from holding Dermata Therapeutics or give up 7.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dermata Therapeutics vs. Brainstorm Cell Therapeutics
Performance |
Timeline |
Dermata Therapeutics |
Brainstorm Cell Ther |
Dermata Therapeutics and Brainstorm Cell Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dermata Therapeutics and Brainstorm Cell
The main advantage of trading using opposite Dermata Therapeutics and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.Dermata Therapeutics vs. Beam Therapeutics | Dermata Therapeutics vs. Editas Medicine | Dermata Therapeutics vs. Caribou Biosciences | Dermata Therapeutics vs. Verve Therapeutics |
Brainstorm Cell vs. Protalix Biotherapeutics | Brainstorm Cell vs. Corvus Pharmaceuticals | Brainstorm Cell vs. Aldeyra | Brainstorm Cell vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |